Cargando…
COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States
The global pandemic of COVID-19 is colliding with the epidemic of opioid use disorders (OUD) and other substance use disorders (SUD) in the United States (US). Currently, there is limited data on risks, disparity, and outcomes for COVID-19 in individuals suffering from SUD. This is a retrospective c...
Autores principales: | Wang, Quan Qiu, Kaelber, David C., Xu, Rong, Volkow, Nora D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488216/ https://www.ncbi.nlm.nih.gov/pubmed/32929211 http://dx.doi.org/10.1038/s41380-020-00880-7 |
Ejemplares similares
-
Correction: COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States
por: Wang, Quan Qiu, et al.
Publicado: (2020) -
DNA sequence-level analyses reveal potential phenotypic modifiers in a large family with psychiatric disorders
por: Ryan, Niamh M., et al.
Publicado: (2018) -
Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs
por: Le-Niculescu, H., et al.
Publicado: (2021) -
Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids
por: Sawada, Tomoyo, et al.
Publicado: (2020) -
Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs
por: Roseberry, K., et al.
Publicado: (2023)